GlassScriptPhysician profile
Jamie C Zampell
NPI 1922281187
$9,643.46
in general payments reported to CMS, 2019-2025
15 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $880 · 2021: $2,709 · 2022: $4,186 · 2023: $310 · 2024: $465 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,095.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $5,548.18 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $979.95 | 2021 | |
| Tepha INC | $825.06 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $725.08 | 2019 | |
| Mentor Worldwide LLC | $358.93 | 2022-2024 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Polynovo North America LLC | $331.28 | 2023-2024 | Novosorb Btm |
| Abbvie INC. | $257.64 | 2024-2025 | |
| Allergan, INC. | $193.45 | 2020-2022 | |
| Davol INC. | $174.41 | 2019-2022 | |
| Becton, Dickinson and Company | $146.45 | 2025 | Phasix Mesh |
| Boston Scientific Corporation | $43.67 | 2022 | |
| Biocomposites INC | $23.89 | 2025 | Stimulan |
| Apria Healthcare LLC | $12.92 | 2021 | |
| Axogen | $12.76 | 2023 | Avance Nerve Graft |
| Polarityte, INC. | $9.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Zampell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.